The BioCentury Show
The BioCentury Show
BioCentury
Ep. 93 – BIO’s Fritz Bittenbender on Trump 2.0, MFN Threats & Pharma’s Concessions
34 minutes Posted Sep 18, 2025 at 9:00 pm.
Introduction
MFN Drug Pricing
Tariffs
China Policy
Vaccines
IRA
0:00
34:03
Download MP3
Show notes
President Donald Trump’s demands for “most favored nation” drug pricing presents the biopharma industry with an immense public policy challenge. Drug companies are convinced that meeting the president’s demand to reduce U.S. prices to levels below those of other industrialized countries would decimate the industry. On this episode of The BioCentury Show, Fritz Bittenbender, SVP of Roche's Genentech unit and chairman of BIO, discusses the industry’s responses to the MFN challenge, and some of ...